Iridex (IRIX) Cost of Revenue (2016 - 2025)
Historic Cost of Revenue for Iridex (IRIX) over the last 17 years, with Q3 2025 value amounting to $8.5 million.
- Iridex's Cost of Revenue rose 1671.26% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.3 million, marking a year-over-year increase of 567.33%. This contributed to the annual value of $29.2 million for FY2024, which is 297.72% down from last year.
- Iridex's Cost of Revenue amounted to $8.5 million in Q3 2025, which was up 1671.26% from $8.9 million recorded in Q2 2025.
- Over the past 5 years, Iridex's Cost of Revenue peaked at $17.0 million during Q1 2022, and registered a low of $6.8 million during Q1 2025.
- Over the past 5 years, Iridex's median Cost of Revenue value was $7.5 million (recorded in 2022), while the average stood at $8.1 million.
- Its Cost of Revenue has fluctuated over the past 5 years, first skyrocketed by 9192.24% in 2021, then crashed by 4983.24% in 2022.
- Iridex's Cost of Revenue (Quarter) stood at $7.5 million in 2021, then rose by 14.02% to $8.5 million in 2022, then decreased by 11.23% to $7.6 million in 2023, then dropped by 6.11% to $7.1 million in 2024, then grew by 19.14% to $8.5 million in 2025.
- Its last three reported values are $8.5 million in Q3 2025, $8.9 million for Q2 2025, and $6.8 million during Q1 2025.